Del Mar Analysts Recommendations and Consensus

Del Mar Pharmaceuticals Inc -- USA Stock  

USD 1.4  0.09  6.87%

The current analyst and expert consensus on Del Mar is Strong Buy with 0 strong sell and 3 strong buy opinions. The current projected target price consensus is 14.84 with 5 analysts opinions. The most common way Del Mar Pharmaceuticals analysists use to provide recommendation to public is financial statements analysis. Many experts also interview Del Mar executives and customers to further validate their buy or sell advice. Please note, the number of analysists providing the opinion is not sufficient to provide adequate consensus on Del Mar. We encourage you to use your own analysis of Del Mar Pharmaceuticals to validate this buy or sell advice. Del Mar buy or sell recommendation module provides average expert sentiment on the projected Del Mar Pharmaceuticals target price to derive its highest and lowest estimates based on projected price volatility of 3.335. Additionally see Macroaxis Advice on Del Mar to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the prospective of investor risk tolerance and investment horizon.

Del Mar Target Price Consensus

Number of Opinions3
Lowered Outlook0
Raized Outlook0
Strong Buy
Macroaxis Recommendation   Exposure   Valuation

Current Price

Del Mar Market Quote
Low Price1.31Odds
High Price1.43Odds


Target Price

Analyst Consensus On Target Price
Low Estimate11.0Odds
High Estimate19.2Odds
Number of Analysts5
Standard Deviation3.335


Del Mar Analysit Ratings

Average Consensus